1. Home
  2. KTTA vs SMSI Comparison

KTTA vs SMSI Comparison

Compare KTTA & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.44

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo Smith Micro Software Inc.

SMSI

Smith Micro Software Inc.

BUY

Current Price

$2.54

Market Cap

14.8M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
KTTA
SMSI
Founded
2020
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
14.8M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
KTTA
SMSI
Price
$0.44
$2.54
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $11.00
AVG Volume (30 Days)
★ 141.8K
14.8K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 77.07
62.94
EPS
★ N/A
N/A
Revenue
$486,559.00
★ $17,363,000.00
Revenue This Year
N/A
$12.88
Revenue Next Year
N/A
$56.63
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 3130.37
N/A
52 Week Low
$0.28
$0.41
52 Week High
$2.06
$6.13

Technical Indicators

Market Signals
Indicator
KTTA
SMSI
Relative Strength Index (RSI) 35.47 34.50
Support Level $0.43 $2.55
Resistance Level $0.52 $3.03
Average True Range (ATR) 0.03 0.08
MACD -0.01 -0.01
Stochastic Oscillator 9.01 1.06

Price Performance

Historical Comparison
KTTA
SMSI

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.

Share on Social Networks: